GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England). 2020;395(10225):709–33.
Article
Google Scholar
Scirica BM, Mosenzon O, Bhatt DL, Udell JA, Steg PG, McGuire DK, et al. Cardiovascular outcomes according to urinary albumin and kidney disease in patients with type 2 diabetes at high cardiovascular risk: observations from the SAVOR-TIMI 53 trial. JAMA Cardiol. 2018;3(2):155–63.
Article
PubMed
Google Scholar
de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation. 2004;110(8):921–7.
Article
PubMed
CAS
Google Scholar
Tanaka F, Komi R, Makita S, Onoda T, Tanno K, Ohsawa M, et al. Low-grade albuminuria and incidence of cardiovascular disease and all-cause mortality in nondiabetic and normotensive individuals. J Hypertens. 2016;34(3):506–12 discussion 12.
Article
CAS
PubMed
Google Scholar
Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. Jama. 2001;286(4):421–6.
Article
CAS
PubMed
Google Scholar
Ruan XZ, Varghese Z, Moorhead JF. An update on the lipid nephrotoxicity hypothesis. Nat Rev Nephrol. 2009;5(12):713–21.
Article
CAS
PubMed
Google Scholar
Gyebi L, Soltani Z, Reisin E. Lipid nephrotoxicity: new concept for an old disease. Curr Hypertens Rep. 2012;14(2):177–81.
Article
CAS
PubMed
Google Scholar
Su H, Wan C, Lei CT, Zhang CY, Ye C, Tang H, et al. Lipid deposition in kidney diseases: interplay among redox, lipid mediators, and renal impairment. Antioxid Redox Signal. 2018;28(10):1027–43.
Article
CAS
PubMed
Google Scholar
Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int. 2000;58(1):293–301.
Article
CAS
PubMed
Google Scholar
Tien KJ, Tu ST, Chen HC, Hsiao JY, Hsieh MC. Triglycerides are independently associated with albuminuria in Taiwanese type 2 diabetic patients. J Endocrinol Investig. 2012;35(9):800–3.
CAS
Google Scholar
Nam KH, Chang TI, Joo YS, Kim J, Lee S, Lee C, et al. Association between serum high-density lipoprotein cholesterol levels and progression of chronic kidney disease: results from the KNOW-CKD. J Am Heart Assoc. 2019;8(6):e011162.
Article
PubMed
PubMed Central
Google Scholar
Wang YX, Wang AP, Ye YN, Gao ZN, Tang XL, Yan L, et al. Elevated triglycerides rather than other lipid parameters are associated with increased urinary albumin to creatinine ratio in the general population of China: a report from the REACTION study. Cardiovasc Diabetol. 2019;18(1):57.
Article
PubMed
PubMed Central
Google Scholar
Sánchez-Íñigo L, Navarro-González D, Pastrana-Delgado J, Fernández-Montero A, Martínez JA. Association of triglycerides and new lipid markers with the incidence of hypertension in a Spanish cohort. J Hypertens. 2016;34(7):1257–65.
Article
PubMed
CAS
Google Scholar
Holman RR, Coleman RL, Shine BS, Stevens RJ. Non-HDL cholesterol is less informative than the total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetes. Diabetes Care. 2005;28(7):1796–7.
Article
CAS
PubMed
Google Scholar
Chabowski DS, Cohen KE, Abu-Hatoum O, Gutterman DD, Freed JK. Crossing signals: bioactive lipids in the microvasculature. Am J Physiol Heart Circ Physiol. 2020;318(5):H1185–h97.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wen J, Chen Y, Huang Y, Lu Y, Liu X, Zhou H, et al. Association of the TG/HDL-C and non-HDL-C/HDL-C ratios with chronic kidney disease in an adult Chinese population. Kidney Blood Pressure Res. 2017;42(6):1141–54.
Article
CAS
Google Scholar
Giannini C, Santoro N, Caprio S, Kim G, Lartaud D, Shaw M, et al. The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds. Diabetes Care. 2011;34(8):1869–74.
Article
PubMed
PubMed Central
Google Scholar
Lin D, Qi Y, Huang C, Wu M, Wang C, Li F, et al. Associations of lipid parameters with insulin resistance and diabetes: A population-based study. Clin Nutr (Edinburgh, Scotland). 2018;37(4):1423–9.
Article
CAS
Google Scholar
Fukuda Y, Hashimoto Y, Hamaguchi M, Fukuda T, Nakamura N, Ohbora A, et al. Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study. Liver Int. 2016;36(5):713–20.
Article
CAS
PubMed
Google Scholar
Young KA, Maturu A, Lorenzo C, Langefeld CD, Wagenknecht LE, Chen YI, et al. The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance, β-cell function, and diabetes in Hispanics and African Americans. J Diabetes Complicat. 2019;33(2):118–22.
Article
Google Scholar
Chen Z, Chen G, Qin H, Cai Z, Huang J, Chen H, et al. Higher triglyceride to high-density lipoprotein cholesterol ratio increases cardiovascular risk: 10-year prospective study in a cohort of Chinese adults. J Diabetes Investigation. 2020;11(2):475–81.
Article
CAS
Google Scholar
Sun K, Lin D, Li F, Huang C, Qi Y, Xue S, et al. Discordant associations of lipid parameters with albuminuria and chronic kidney disease: a population-based study. Lipids Health Dis. 2015;14:152.
Article
PubMed
PubMed Central
CAS
Google Scholar
Ning G. Risk evaluation of cAncers in Chinese diabeTic individuals: a lONgitudinal (REACTION) study. J Diabetes. 2012;4(2):172–3.
Article
PubMed
Google Scholar
Stevens LA, Claybon MA, Schmid CH, Chen J, Horio M, Imai E, et al. Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int. 2011;79(5):555–62.
Article
PubMed
Google Scholar
2. Classification and Diagnosis of Diabetes. Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13–s27.
Google Scholar
Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. Jama. 2007;298(7):776–85.
Article
CAS
PubMed
Google Scholar
Kang HT, Kim JK, Kim JY, Linton JA, Yoon JH, Koh SB. Independent association of TG/HDL-C with urinary albumin excretion in normotensive subjects in a rural Korean population. Clinica Chimica Acta. 2012;413(1–2):319–24.
Article
CAS
Google Scholar
Gu S, Wang A, Ning G, Zhang L, Mu Y. Insulin resistance is associated with urinary albumin-creatinine ratio in normal weight individuals with hypertension and diabetes: the REACTION study. J Diabetes. 2020;12(5):406–16.
Article
CAS
PubMed
Google Scholar
Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity, kidney dysfunction and hypertension: mechanistic links. Nat Rev Nephrol. 2019;15(6):367–85.
Article
PubMed
PubMed Central
Google Scholar
Agrawal S, Zaritsky JJ, Fornoni A, Smoyer WE. Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat Rev Nephrol. 2018;14(1):57–70.
Article
CAS
PubMed
Google Scholar
Vaziri ND. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol. 2006;290(2):F262–72.
Article
CAS
PubMed
Google Scholar
Welsh GI, Hale LJ, Eremina V, Jeansson M, Maezawa Y, Lennon R, et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab. 2010;12(4):329–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Artunc F, Schleicher E, Weigert C, Fritsche A, Stefan N, Häring HU. The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol. 2016;12(12):721–37.
Article
CAS
PubMed
Google Scholar
Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol. 2016;311(6):F1087–f108.
Article
CAS
PubMed
Google Scholar
Bussolati B, Deregibus MC, Fonsato V, Doublier S, Spatola T, Procida S, et al. Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the phosphatidylinositol 3-kinase/AKT-signaling pathway. J Am Soc Nephrol. 2005;16(7):1936–47.
Article
CAS
PubMed
Google Scholar
Nosadini R, Tonolo G. Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes. Nutr Metabol Cardiovasc Dis. 2011;21(2):79–85.
Article
CAS
Google Scholar
Bhalodkar NC, Blum S, Enas EA. Accuracy of the ratio of triglycerides to high-density lipoprotein cholesterol for predicting low-density lipoprotein cholesterol particle sizes, phenotype B, and particle concentrations among Asian Indians. Am J Cardiol. 2006;97(7):1007–9.
Article
CAS
PubMed
Google Scholar
Carmena R, Duriez P, Fruchart JC. Atherogenic lipoprotein particles in atherosclerosis. Circulation. 2004;109(23 Suppl 1):Iii2–7.
PubMed
Google Scholar
Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet (London, England). 2012;379(9818):815–22.
Article
Google Scholar
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet (London, England). 2013;382(9888):260–72.
Article
Google Scholar
Wahl P, Ducasa GM, Fornoni A. Systemic and renal lipids in kidney disease development and progression. Am J Physiol Renal Physiol. 2016;310(6):F433–45.
Article
CAS
PubMed
Google Scholar
Bakker AJ. Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care. 1999;22(2):307–13.
Article
CAS
PubMed
Google Scholar
Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, Parving HH, et al. Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney. 2003;42(4):617–22.
Article
Google Scholar